Shingles

NICE CKS Shingles. Last revised Nov 2024.

Guidelines

Clinical diagnosis - based on typical clinical features.
 

  • Prodromal phase of 2-3 days
    • Pain in the affected dermatome
    • Abnormal skin sensations (e.g. pruritus, paraesthesia, dysesthesia, numbness)
 
  • Unilateral painful rash in a dermatomal distribution (does not cross midline)
    • Erythematous maculopapular rash for 1-2 days
    • → Vesicles for 3-4 days
    • → Pustules within 1 week
    • → Ulceration and crusting after 3-5 days
    • → Healing over 2-4 weeks, often with scarring and permanent pigmentation

Admit or seek immediate specialist advice if ANY of the following:
  • Immunocompromised (severely immunocompromised adult / immunocompromised children)
  • Shingles in the ophthalmic distribution of CN V, especially those with:
    • Hutchinson's sign (rash on the nose, representing the dermatome of the nasociliary nerve, is associated with a high complication rate.)
    • Eye pain
    • Photophobia
    • Reduced corneal sensitivity
    • Visual impairment
    • An unexplained red eye
  • Head and neck involved (esp. in elderly people)
  • Signs of visceral / CNS involvement (including vasculitis)
  • Haemorrhagic / necrotic lesions, multisegmental involvement, aberrant vesicles/satellite lesions, mucosal involvement or generalised herpes zoster.

Advise that shingles is infectious until all vesicles have crusted over (~7 days after rash onset).
  • Patient should avoid work / school / daycare if the rash is weeping and cannot be covered

Measures to prevent transmission:
  • Avoid skin contact with people at high risk of complications 
  • Avoid sharing clothes and towels
  • Wash their hands often

Skin / rash care measures:
  • Avoid touching / scratching the rash 
  • Avoid using topical antibiotics and adhesive dressing
  • Keep rash clean and dry to reduce risk of bacterial superinfection
  • Wear loose fitting clothes 
  • Cover lesions that are not under clothes if it is still weeping

Scenarior Management
Mild to moderate pain
  • Paracetamol / NSAID 
  • +/- Weak opioid
Moderate to severe pain Neuropathic pain drugs:
  • Amitriptyline
  • Duloxetine
  • Pregabalin 
  • Gabapentin

Also consider oral steroids, but only if immunocompetent and given in combination with antiviral.
If oral treatment not appropriate Topical capsaicin cream
 

Indications for anit-viral therapy (any of the following):
  • Immunocompromised
  • >50 y/o
  • Non-truncal invovlement
  • Moderate / severe pain
  • Presence of predisposing skin conditions 

Anti-viral therapy should not be offered to immunocompetent children.

Choice of anti-viral therapy:
  • 1st line: oral aciclovir / valaciclovir / famciclovir for 7 days
  • To be started within 72 hours of rash onset (if not possible, consider up to 1 week after rash onset)
 

Anti-viral therapy is established to reduce the risk of post-herpetic neuralgia, esp. in older patients. 

2 doses of Shingrix vaccine are routinely offered to all immunocompetent people at 60 y/o

 

Currently, it is under a 10-year implementation period. 

References

Author: Adams Lau
Reviewer:
Last edited: 24/04/25